News Conference News ACC 2023 No Downside to Immediate Complete Revascularization in ACS: BIOVASC Michael O'Riordan March 06, 2023
News Daily News For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI Michael O'Riordan February 23, 2023
News Daily News Interventional Cardiology Training Needs Defined for the First Time Yael L. Maxwell February 20, 2023
News Daily News Risk of Sports-Related Sudden Cardiac Arrest Low in Older Adults Michael O'Riordan February 09, 2023
News Daily News UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy Michael O'Riordan January 20, 2023
News Features Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends Michael O'Riordan January 06, 2023
News Daily News Anatomic Disease After PCI Linked With Worse Outcomes: VA CART Michael O'Riordan December 22, 2022
News Daily News Less Occlusion, Hematomas With Distal Radial Access: Meta-analysis Michael O'Riordan November 22, 2022
News Daily News Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study Michael O'Riordan November 18, 2022
News Daily News Many STEMI Patients Not Treated Within National Time Goals Michael O'Riordan November 15, 2022
News Daily News New Biomarker-Based Risk Score Performs Well in ACS Michael O'Riordan October 25, 2022
News Daily News NSTEMI Patients With CKD: Early Invasive vs Delayed Strategy Similar for Survival Caitlin E. Cox October 03, 2022
News Conference News ESC 2022 CV Care Around Noncardiac Surgery: New ESC Guidelines Michael O'Riordan September 07, 2022
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Conference News ESC 2022 DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark L.A. McKeown August 30, 2022
News Conference News ESC 2022 P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER Todd Neale August 29, 2022
News Conference News ESC 2022 ‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR Shelley Wood August 28, 2022
News Features Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD? Michael O'Riordan August 15, 2022